Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Xiangya Hospital of Central South University

6 clinical trials · 6 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Xiangya Hospital of Central South University

RECRUITINGNCT06341231

Personalized Anticoagulant Therapy for Pulmonary Thromboembolism

The goal of this prospective observational study is to explore the influencing factors of the efficacy and safety of anticoagulant therapy for pulmonary thromboembolism in special...

Sponsor: Xiangya Hospital of Central South UniversityEnrolling: 47001 location
Pulmonary ThromboembolismsAnticoagulants; Increased
RECRUITINGNCT05466565

Antiviral Therapy for Patients With Liver Cancer After Surgery

This is a single-center, prospective, observational, real world study designed to evaluate the effects of peginterferon α-2b(pegabin) combined with nucleoside (acid) analogs...

Sponsor: Xiangya Hospital of Central South UniversityEnrolling: 3601 location
Hepatocellular Carcinoma
RECRUITINGNCT03523104

Chinese PD-LRRK2 Registry

The purpose of the Chinese PD-LRRK2 Registry(CPD-LRRK2R) is to develop a database of patients of Parkinson's disease with leucine-rich repeat kinase 2 (LRRK2) gene variants in...

Sponsor: Xiangya Hospital of Central South UniversityEnrolling: 10001 location
Parkinson Disease
RECRUITINGNCT03523052

Chinese PD-SNCA Registry

The purpose of the Chinese PD-SNCA Registry(CPD-SNCAR) is to develop a database of patients of Parkinson's disease with a-synuclein (SNCA) gene variants in mainland China.

Sponsor: Xiangya Hospital of Central South UniversityEnrolling: 30001 location
Parkinson Disease
RECRUITINGNCT05392387

Treatment and Prognosis of Patients With Chronic HBV Infection

Hepatitis B virus (HBV) infection is a major global health issue with 257 million chronically infected individuals. Of note, China has the largest population accounting for one...

Sponsor: Xiangya Hospital of Central South UniversityEnrolling: 5001 location
Hepatitis B Virus Infection
RECRUITINGNCT06746701

Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.

This is a retrospective prospective, open-label, multicenter clinical study aiming to recruit 400 individuals with a family history of liver cancer to explore the clinical cure...

Sponsor: Xiangya Hospital of Central South UniversityEnrolling: 4004 locations
HBV